ArriVent BioPharma, Inc.
AVBP
$20.82
-$0.35-1.65%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.62% | -5.29% | -5.90% | 111.05% | -9.60% |
| Total Receivables | 0.00% | -33.33% | -14.29% | 14.98% | -30.12% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -64.33% | -6.86% | -15.75% | 295.11% | 28.67% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -8.77% | 0.44% | 1.41% | -8.19% | -30.99% |
| Total Current Assets | -22.37% | -5.22% | -5.79% | 104.72% | -11.12% |
|
|
|||||
| Total Current Assets | -22.37% | -5.22% | -5.79% | 104.72% | -11.12% |
| Net Property, Plant & Equipment | -17.65% | -14.61% | -12.40% | -14.09% | 561.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.80% | 15.74% | -96.20% | 44.63% |
| Total Assets | -6.07% | -5.23% | -5.79% | 101.01% | -10.38% |
|
|
|||||
| Total Accounts Payable | -18.60% | 21.88% | -6.98% | -9.58% | -5.94% |
| Total Accrued Expenses | 28.68% | 27.35% | 41.91% | -17.55% | 32.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.18% | 3.29% | 3.40% | 5.00% | 218.18% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 13.93% | 25.33% | 21.26% | -14.17% | 15.09% |
|
|
|||||
| Total Current Liabilities | 13.93% | 25.33% | 21.26% | -14.17% | 15.09% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -75.00% | -42.86% | -28.99% | -22.03% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.60% | 24.78% | 20.57% | -14.29% | 16.84% |
|
|
|||||
| Common Stock & APIC | 0.20% | 0.28% | 0.16% | 10,497.27% | 11.99% |
| Retained Earnings | -9.48% | -10.43% | -12.48% | -11.03% | -15.51% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -7.15% | -6.46% | -6.63% | 307.40% | -15.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
|
|
|||||
| Total Common Equity | -7.15% | -6.46% | -6.63% | 307.40% | -15.53% |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.15% | -6.46% | -6.63% | 110.00% | -11.98% |
|
|
|||||